Evaluation of the lymphoid compartment revealed that ciforadenant increased the frequency of polyfunctional CD8+ T cells, whereas PD-1 blockade enhanced the infiltration of T cells and NK cells into tumours (Extended Data Fig. 9a–c). Here, CD8A is linked to neoplasm.